EQV Ventures Acquisition Corp. II (EVAC): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.09M

As of 2025-12-31

$1.11M

As of 2026-06-30

Period ended	Cash & Equivalents	Change YoY	Source filing
2025-12-31	$1.09M	n/a	2026-03-27, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cash & Equivalents	Change YoY
EQV Ventures Acquisition Corp. II (EVAC)	2025-12-31	$1.09M	n/a
Bain Capital GSS Investment Corp. (BCSS)	2025-12-31	$0	n/a
Cantor Equity Partners IV, Inc. (CEPF)	2025-12-31	$25.0K	n/a
Drugs Made In America Acquisition II Corp. (DMII)	2025-12-31	$223	n/a
Innventure, Inc. (INV)	2025-12-31	$60.45M	+443.7%
American Exceptionalism Acquisition Corp. A (AEXA)	2025-12-31	$0	n/a
Apex Treasury Corp (APXT)	2025-12-31	$991.5K	n/a
Berto Acquisition Corp. (TACO)	2025-12-31	$0	n/a
Velos Acquisition I Corp. (VLOS)	2025-12-31	$0	n/a

Compare EVAC, BCSS, CEPF, DMII side by side · Screen every company in Blank Checks ↗